ClinicalTrials HQ

Norcross

Norcross

Norcross, Georgia, United States

16 results · Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migrainebrain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderRecruitingPhase 32026-10-07NCT07816367
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderCannabis WithdrawalRecruitingPhase 32026-09-28NCT07644052
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsInsulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, prediabetes syndrome, type 2 diabetes mellitusRecruitingNot applicable2026-09-28NCT06112418
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)depressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22026-09-25NCT07621237
RE104 Safety and Efficacy Study in Generalized Anxiety Disorderanxiety disorder, generalized anxiety disorder, psychiatric disorderRecruitingPhase 22026-09-24NCT07489651
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infectionRecruitingPhase 32026-09-08NCT07629440
Open-Label Safety Study of AXS-14 in Subjects With FibromyalgiaHyperalgesia, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorderEnrolling by invitationPhase 32026-09-04NCT07637162
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research DesignHyperalgesia, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorderRecruitingPhase 32026-09-04NCT07398417
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, acquired idiopathic inflammatory myopathy, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diffuse scleroderma, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, scleroderma, skin disorder, systemic sclerosisRecruitingPhase 22026-07-31NCT06991114
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolDisorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, depressive disorder, major depressive disorder, mood disorder, nervous system disorder, psychiatric disorder, sleep-wake disorderRecruitingPhase 32026-07-24NCT07484217
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderRecruitingPhase 32026-07-13NCT05712200
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22026-06-15NCT07276997
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitusActive, not recruitingPhase 22026-03-23NCT06037252
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlareCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorderRecruitingPhase 22025-12-08NCT07145229
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibroid Uterus, Genital Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, connective tissue neoplasm, endometriosis, female reproductive system disorder, leiomyoma, myofibroma, myomatous neoplasm, neoplasmRecruitingPhase 32025-08-06NCT05862272
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency DisorderEpilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, epilepsy, nervous system disorderActive, not recruitingNot stated2025-03-10NCT05373719